Phenex is a privately financed biotechnology company that focuses on developing novel drug candidates that act on Nuclear Receptors, a pharmacologically well accepted drug target class. Nuclear receptors are of major importance for the body's homeostasis, as they integrate different intra- and extracellular signalling to initiate and regulate gene expression programs. This key role in a wide variety of signalling pathways qualifies them as important pharmacological targets. Nuclear receptor modulating drugs account for about 10% revenues of the total ethical drug market, applied in different indications, such as Hormone Replacement Therapy, Women's Health, Inflammation, Diabetes, Cancer and Dermatology.
Funding Rounds (2) - $12.9MUpdate
25 years of successful venture capital
EVP Capital Management AG ist eine Private Equity Gesellschaft, die als Tochter der Co-Investor...
KfW Bankengruppe gives impetus to economic, social and ecological development worldwide. As a...
Waldhofer Str. 104
Ludwigshafen Am Rhein-oggersheim, 67059